FDA Import Refusal SCS-3327961-6/11/1 — HIMALAYA DRUG COMPANY
The FDA refused shipment SCS-3327961-6/11/1 from HIMALAYA DRUG COMPANY (India) on Sep 8, 2022. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 8, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66VBA99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,3280,75